Remove publications issue
article thumbnail

Opinion: Peter Hotez is not alone: Online harassment of doctors is a public health issue

STAT

Father’s Day weekend was anything but calm on Twitter, which erupted as vaccine expert Peter Hotez was challenged online to a debate by podcaster and former reality TV host Joe Rogan.

Vaccines 363
article thumbnail

STAT+: New, serious safety risk related to MorphoSys’ cancer drug complicates, potentially threatens, Novartis acquisition

STAT

MorphoSys is dealing with an emerging safety issue related to pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis, STAT has learned. They spoke on the condition of anonymity because the cases have not been reported publicly.

354
354
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Lawmakers unlikely to permanently extend telehealth flexibilities this year

STAT

WASHINGTON — Members of Congress appear poised to advance another short-term extension of pandemic-era telehealth flexibilities instead of permanently addressing the issue, seven sources familiar with the talks said. Continue to STAT+ to read the full story…

Packaging 284
article thumbnail

Florida health officials provide scant details on measles cases, worrying health experts

STAT

On Sunday, public health officials in two Michigan counties warned their residents that they may have been exposed to measles.

Hospitals 364
article thumbnail

STAT+: Health care lobbying giants spent big as little got done in Congress

STAT

And noncontroversial public health programs had to be paid for in a massive government spending bill, which can shield members of Congress from taking votes on any one issue alone. Two committees in the Senate passed significant reforms to how PBMs operate in Medicaid, Medicare, and the commercial insurance market.

Packaging 334
article thumbnail

STAT+: Colombia issues a compulsory license for an HIV medicine and ‘plants a flag for global health equity’

STAT

After months of deliberation, the Colombian government has issued a compulsory license for an HIV medicine, the first time the country has taken such a step, one that also marks a significant move in the increasingly global battle over access to medicines.

349
349
article thumbnail

STAT+: Colombia proceeds with plans to issue a compulsory license for an HIV medicine sold by GSK’s ViiV

STAT

The Colombian government has taken a significant step toward issuing a compulsory license for a widely used HIV treatment, the latest instance in which cash-strapped governments battle with the pharmaceutical industry over the cost of medicines.

353
353